Endocrine Physiology in Relation to Sleep and Sleep Disturbances

Principles and Practice of Sleep Medicine: Fifth Edition

Volumn , Issue , 2010, Pages 291-311

  Van Cauter, Eve ^a   Tasali, Esra ^b  

^a Department of Medicine ^*  (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84906843074     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-6645-3.00026-8     Document Type: Chapter

References (190)

1. Bouatia-Naji N, Bonnefond A, Cavalcanti-Proenca C, et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 2009, 41:89-94.
2. Lyssenko V, Nagorny CL, Erdos MR, et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet 2009, 41:82-88.
3. Prokopenko I, Langenberg C, Florez JC, et al. Variants in MTNR1B influence fasting glucose levels. Nat Genet 2009, 41:77-81.
4. Green CB, Takahashi JS, Bass J The meter of metabolism. Cell 2008, 134:728-742.
5. Van Cauter E, Blackman JD, Roland D, et al. Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep. J Clin Invest 1991, 88:934-942.
6. van der Lely AJ, Tschop M, Heiman ML, et al. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004, 25(3):426-457.
7. Obal F, Krueger JM GHRH and sleep. Sleep Med Rev 2004, 8:367-377.
8. Van Cauter E, Plat L, Copinschi G Interrelations between sleep and the somatotropic axis. Sleep 1998, 21:553-566.
9. Holl RW, Hartmann ML, Veldhuis JD, et al. Thirty-second sampling of plasma growth hormone in man: correlation with sleep stages. J Clin Endocrinol Metab 1991, 72:854-861.
10. Van Cauter E, Kerkhofs M, Caufriez A, et al. A quantitative estimation of GH secretion in normal man: reproducibility and relation to sleep and time of day. J Clin Endocrinol Metab 1992, 74:1441-1450.
11. Gronfier C, Luthringer R, Follenius M, et al. A quantitative evaluation of the relationships between growth hormone secretion and delta wave electroencephalographic activity during normal sleep and after enrichment in delta waves. Sleep 1996, 19:817-824.
12. Van Cauter E, Plat L, Scharf M, et al. Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young men. J Clin Invest 1997, 100:745-753.
13. Aeschbach D, Dijk DJ, Trachsel L, et al. Dynamics of slow-wave activity and spindle frequency activity in the human sleep EEG: effect of midazolam and zopiclone. Neuropsychopharmacology 1994, 11:237-244.
14. Obal F, Krueger JM Biochemical regulation of non-rapid-eye-movement sleep. Front Biosci 2003, 8:d520-550.
15. Ocampo-Lim B, Guo W, DeMott Friberg R, et al. Nocturnal growth hormone (GH) secretion is eliminated by infusion of GH-releasing Hormone antagonist. J Clin Endocrinol Metab 1996, 81:4396-4399.
16. Jaffe C, Turgeon D, DeMott Friberg R, et al. Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin-a clinical research center study. J Clin Endocrinol Metab 1995, 80:3321-3326.
17. Dzaja A, Dalal MA, Himmerich H, et al. Sleep enhances nocturnal plasma ghrelin levels in healthy subjects. Am J Physiol Endocrinol Metab 2004, 286(6):E963-E967.
18. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002, 346:1623-1630.
19. Brandenberger G, Gronfier C, Chapotot F, et al. Effect of sleep deprivation on overall 24 h growth-hormone secretion. Lancet 2000, 356(9239):1408.
20. Jarrett DB, Greenhouse JB, Miewald JM, et al. A reexamination of the relationship between growth hormone secretion and slow wave sleep using delta wave analysis. Biol Psychiatry 1990, 27:497-509.
21. Mendlewicz J, Linkowski P, Kerkhofs M, et al. Diurnal hypersecretion of growth hormone in depression. J Clin Endocrinol Metab 1985, 60:505-512.
22. Steiger A, Herth T, Holsboer F Sleep-electroencephalography and the secretion of cortisol and growth hormone in normal controls. Acta Endocrinol 1987, 116:36-42.
23. Spiegel K, Leproult R, Colecchia E, et al. Adaptation of the 24-hour growth hormone profile to a state of sleep debt. Am J Physiol 2000, 279:R874-R883.
24. Van Cauter E, Caufriez A, Kerkhofs M, et al. Sleep, awakenings and insulin-like growth factor I modulate the growth hormone secretory response to growth hormone-releasing hormone. J Clin Endocrinol Metab 1992, 74:1451-1459.
25. Spath-Schwalbe E, Gofferje M, Kern W, et al. Sleep disruption alters nocturnal ACTH and cortisol secretory patterns. Biol Psychiatry 1991, 29:575-584.
26. Born J, Muth S, Fehm HL The significance of sleep onset and slow wave sleep for nocturnal release of growth hormone (GH) and cortisol. Psychoneuroendocrinology 1988, 13:233-243.
27. Weibel L, Follenius M, Spiegel K, et al. Comparative effect of night and daytime sleep on the 24-hour cortisol secretory profile. Sleep 1995, 18:549-556.
28. Gronfier C, Luthringer R, Follenius M, et al. Temporal relationships between pulsatile cortisol secretion and electroencephalographic activity during sleep in man. Electroencephalogr Clin Neurophysiol 1997, 103:405-408.
29. Bierwolf C, Struve K, Marshall L, et al. Slow wave sleep drives inhibition of pituitary-adrenal secretion in humans. J Neuroendocrinol 1997, 9:479-484.
30. Brabant G, Prank K, Ranft U, et al. Physiological regulation of circadian and pulsatile thyrotropin secretion in normal man and woman. J Clin Endocrinol Metab 1990, 70:403-409.
31. Pruessner JC, Wolf OT, Hellhammer DH, et al. Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci 1997, 61:2539-2549.
32. Leproult R, Copinschi G, Buxton O, et al. Sleep loss results in an elevation of cortisol levels the next evening. Sleep 1997, 20:865-870.
33. Veldhuis JD, Iranmanesh A, Johnson ML, et al. Twenty-four-hour rhythms in plasma concentrations of adenohypophyseal hormones are generated by distinct amplitude and/or frequency modulation of underlying pituitary secretory bursts. J Clin Endocrinol Metab 1990, 71:1616-1623.
34. Parker DC, Rossman LG, Pekary AE, et al. Effect of 64-hour sleep deprivation on the circadian waveform of thyrotropin (TSH): further evidence of sleep-related inhibition of TSH release. J Clin Endocrinol Metab 1987, 64:157-161.
35. Van Cauter E, Copinschi G Endocrine and other biological rhythms. Endocrinology 2006, 341-372. Elsevier Saunders, Philadelphia. L.J. DeGroot, J.L. Jameson (Eds.).
36. Allan JS, Czeisler CA Persistence of the circadian thyrotropin rhythm under constant conditions and after light-induced shifts of circadian phase. J Clin Endocrinol Metab 1994, 79:508-512.
37. Gary KA, Winokur A, Douglas SD, et al. Total sleep deprivation and the thyroid axis: effects of sleep and waking activity. Aviat Space Environ Med 1996, 67:513-519.
38. Spiegel K, Leproult R, L'Hermite-Baleriaux M, et al. Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. J Clin Endocrinol Metab 2004, 89:5762-5771.
39. Spiegel K, Leproult R, Van Cauter E Impact of sleep debt on metabolic and endocrine function. Lancet 1999, 354:1435-1439.
40. Hirschfeld U, Moreno-Reyes R, Akseki E, et al. Progressive elevation of plasma thyrotropin during adaptation to simulated jet lag: effects of treatment with bright light or zolpidem. J Clin Endocrinol Metab 1996, 81:3270-3277.
41. Spiegel K, Follenius M, Simon C, et al. Prolactin secretion and sleep. Sleep 1994, 17:20-27.
42. Waldstreicher J, Duffy JF, Brown EN, et al. Gender differences in the temporal organization of prolactin (PRL) secretion: evidence fort a sleep-independent circadian rhythm of circulating PRL levels-a clinical research Center study. J Clin Endocrinol Metab 1996, 81:1483-1487.
43. Désir D, Van Cauter E, L'Hermite M, et al. Effects of "jet lag" on hormonal patterns. III. Demonstration of an intrinsic circadian rhythmicity in plasma prolactin. J Clin Endocrinol Metab 1982, 55:849-857.
44. Spiegel K, Luthringer R, Follenius M, et al. Temporal relationship between prolactin secretion and slow-wave electroencephalographic activity during sleep. Sleep 1995, 18:543-548.
45. Copinschi G, Van Onderbergen A, L'Hermite-Balériaux M, et al. Effects of the short-acting benzodiazepine triazolam, taken at bedtime, on circadian and sleep-related hormonal profiles in normal men. Sleep 1990, 13:232-244.
46. Copinschi G, Akseki E, Moreno-Reyes R, et al. Effects of bedtime administration of zolpidem on circadian and sleep-related hormonal profiles in normal women. Sleep 1995, 18:417-424.
47. Richardson G, Wang-Weigand S Effects of long-term exposure to ramelteon, a melatonin receptor agonist, on endocrine function in adults with chronic insomnia. Hum Psychopharmacol 2009, 24:103-111.
48. Roky R, Obal F, Valatx JL, et al. Prolactin and rapid eye movement sleep regulation. Sleep 1995, 18:536-542.
49. Obal F, Garcia-Garcia F, Kacsoh B, et al. Rapid eye movement sleep is reduced in prolactin-deficient mice. J Neurosci 2005, 25(44):10282-10289.
50. Fehm HL, Clausing J, Kern W, et al. Sleep-associated augmentation and synchronization of luteinizing hormone pulses in adult men. Neuroendocrinology 1991, 54:192-195.
51. Bremner WJ, Vitiello MV, Prinz PN Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab 1983, 56:1278-1280.
52. Lejeune-Lenain C, Van Cauter E, Desir D, et al. Control of circadian and episodic variations of adrenal androgens secretion in man. J Endocrinol Invest 1987, 10:267-276.
53. Luboshitzky R, Herer P, Levi M, et al. Relationship between rapid eye movement sleep and testosterone secretion in normal men. J Androl 1999, 20:731-737.
54. Axelsson J, Ingre M, Akerstedt T, et al. Effects of acutely displaced sleep on testosterone. J Clin Endocrinol Metab 2005, 90:4530-4535.
55. Luboshitzky R, Zabari Z, Shen-Orr Z, et al. Disruption of the nocturnal testosterone rhythm by sleep fragmentation in normal men. J Clin Endocrinol Metab 2001, 86:1134-1139.
56. Akerstedt T, Palmblad J, de la Torre B, et al. Adrenocortical and gonadal steroids during sleep deprivation. Sleep 1980, 3:23-30.
57. Leibenluft E, Schmidt PJ, Turner EH, et al. Effects of leuprolide-induced hypogonadism and testosterone replacement on sleep, melatonin, and prolactin secretion in men. J Clin Endocrinol Metab 1997, 82:3203-3207.
58. Reame N, Sauder SE, Kelch RP, et al. Pulsatile gonadotropin secretion during the human menstrual cycle: evidence for altered frequency of gonadotropin-releasing hormone secretion. J Clin Endocrinol Metab 1984, 59:328-337.
59. Filicori M, Santoro N, Merriam GR, et al. Characterization of the physiological pattern of episodic gonadotropin secretion throughout the menstrual cycle. J Clin Endocrinol Metab 1986, 62:1136-1144.
60. Hall JE, Sullivan JP, Richardson GS Brief wake episodes modulate sleep-inhibited luteinizing hormone secretion in the early follicular phase. J Clin Endocrinol Metab 2005, 90:2050-2055.
61. Vermeulen A, Deslypere JP, Kaukman JM Influence of antiopioids on luteinizing hormone pulsatility in aging men. J Clin Endocrinol Metab 1989, 68:68-72.
62. Mulligan T, Iranmanesh A, Gheorghiu S, et al. Amplified nocturnal luteinizing hormone (LH) secretory burst frequency with selective attenuation of pulsatile (but not basal) testosterone secretion in healthy aged men: possible Leydig cell desensitization to endogenous LH signaling-a clinical research center study. J Clin Endocrinol Metab 1995, 80:3025-3031.
63. Tenover JS, Matsumoto AM, Clifton DK, et al. Age-related alterations in the circadian rhythms of pulsatile luteinizing hormone and testosterone secretion in healthy men. J Gerontol 1988, 43:M163-M169.
64. Luboshitzky R, Shen-Orr Z, Herer P Middle-aged men secrete less testosterone at night than young healthy men. J Clin Endocrinol Metab 2003, 88:3160-3166.
65. Turek FW, Van Cauter E Rhythms in reproduction. The physiology of reproduction 1993, 1789-1830. Raven Press, New York. K.E. Neill JD (Ed.).
66. Saletu-Zyhlarz G, Anderer P, Gruber G, et al. Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone. J Sleep Res 2003, 12:239-254.
67. Hays J, Ockene JK, Brunner RL, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003, 348:1839-1854.
68. Antonijevic IA, Stalla GK, Steiger A Modulation of the sleep electroencephalogram by estrogen replacement in postmenopausal women. Am J Obstet Gynecol 2000, 182:277-282.
69. Moe KE, Larsen LH, Vitiello MV, et al. Estrogen replacement therapy moderates the sleep disruption associated with nocturnal blood sampling. Sleep 2001, 24:886-894.
70. Shahar E, Redline S, Young T, et al. Hormone replacement therapy and sleep-disordered breathing. Am J Respir Crit Care Med 2003, 167:1186-1192.
71. Van Cauter E, Polonsky KS, Scheen AJ Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr Rev 1997, 18:716-738.
72. Boyle PJ, Scott JC, Krentz AJ, et al. Diminished brain glucose metabolism is a significant determinant for falling rates of systemic glucose utilization during sleep in normal humans. J Clin Invest 1994, 93:529-535.
73. Maquet P Functional neuroimaging of normal human sleep by positron emission tomography. J Sleep Research 2000, 9:207-231.
74. Peschke E Melatonin, endocrine pancreas and diabetes. J Pineal Res 2008, 44:26-40.
75. Scheen AJ, Byrne MM, Plat L, et al. Relationships between sleep quality and glucose regulation in normal humans. Am J Physiol 1996, 271:E261-E270.
76. Plat L, Byrne MM, Sturis J, et al. Effects of morning cortisol elevation on insulin secretion and glucose regulation in humans. Am Journal Physiol 1996, 270:E36-E42.
77. Danguir J, Nicolaidis S Dependence of sleep on nutrients' availability. Physiol Behav 1979, 22:735-740.
78. Rechtschaffen A, Bergmann BM Sleep deprivation in the rat by the disk-over-water method. Behav Brain Res 1995, 69:55-63.
79. Sakurai T The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev 2007, 8:171-181.
80. Adamantidis A, de Lecea L The hypocretins as sensors for metabolism and arousal. J Physiol 2009, 587(Pt 1):33-40.
81. Ahima RS, Lazar MA Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol 2008, 22:1023-1031.
82. Schoeller DA, Cella LK, Sinha MK, et al. Entrainment of the diurnal rhythm of plasma leptin to meal timing. J Clin Invest 1997, 100:1882-1887.
83. Simon C, Gronfier C, Schlienger JL, et al. Circadian and ultradian variations of leptin in normal man under continuous enteral nutrition: relationship to sleep and body temperature. J Clin Endocrinol Metab 1998, 83:1893-1899.
84. Mullington JM, Chan JL, Van Dongen HP, et al. Sleep loss reduces diurnal rhythm amplitude of leptin in healthy men. J Neuroendocrinol 2003, 15:851-854.
85. Havel PJ Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis. Exp Biol Med (Maywood) 2001, 226:963-977.
86. Cummings DE, Frayo RS, Marmonier C, et al. Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues. Am J Physiol Endocrinol Metab 2004, 287:E297-E304.
87. Brandenberger G, Charloux A, Grongier C, et al. Ultradian rhythms in hydromineral hormones. Horm Res 1998, 49:131-135.
88. Follenius M, Brandenberger G, Saini J Lack of diurnal rhythm in plasma atrial natriuretic peptide. Life Sci 1992, 51:143-149.
89. Brandenberger G, Krauth MO, Ehrhart J, et al. Modulation of episodic renin release during sleep in humans. Hypertension 1990, 15:370-375.
90. Brandenberger G, Follenius M, Muzet A, et al. Ultradian oscillations in plasma renin activity: their relationship to meals and sleep stages. J Clin Endocrinol Metab 1985, 61:280-284.
91. Portaluppi F, Bagni B, Degli UB, et al. Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure, and heart rate in normal and hypertensive subjects. J Hypertens 1990, 8:85-95.
92. Brandenberger G, Follenius M, Goichot B, et al. Twenty-four hour profiles of plasma renin activity in relation to the sleep-wake cycle. J Hypertens 1994, 12:277-283.
93. Brandenberger G, Follenius M, Simon C, et al. Nocturnal oscillations in plasma renin activity and REM-NREM sleep cycles in man: a common regulatory mechanism?. Sleep 1988, 11:242-250.
94. Luthringer R, Brandenberger G, Schaltenbrand N, et al. Slow wave electroencephalographic activity parallels renin oscillations during sleep in humans. Electroencephalogr Clin Neurophysiol 1995, 95:318-322.
95. Charloux A, Piquard F, Ehrhart J, et al. Time-courses in renin and blood pressure during sleep in humans. J Sleep Res 2002, 11:73-79.
96. Charloux A, Gronfier C, Lonsdorfer-Wolf E, et al. Aldosterone release during the sleep-wake cycle in humans. Am J Physiol 1998, 276:E43-E49.
97. Charloux A, Gronfier C, Chapotot F, et al. Sleep deprivation blunts the night time increase in aldosterone release in humans. J Sleep Res 2001, 10:27-33.
98. National Sleep Foundation "Sleep in America" Poll http://www.sleepfoundation.org.
99. Institut National de Prévention et d'Education pour la Santé Les français et leur sommeil http://www.inpes.sante.fr/70000/dp/08/dp080310.pdf.
100. Wehr T, Moul D, Barbato G, et al. Conservation of photoperiod-responsive mechanisms in humans. Am J Physiol 1993, 265:R846-R857.
101. Roehrs T, Shore E, Papineau K, et al. A two-week sleep extension in sleepy normals. Sleep 1996, 576-582.
102. Harrison Y, Horme JA Long-term extension to sleep-are we really chronically sleep deprived?. Psychophysiology 1996, 33:22-30.
103. Bergman RN Minimal model: perspective from 2005. Horm Research 2005, 64:8-15.
104. Knutson KL, Van Cauter E Associations between sleep loss and increased risk of obesity and diabetes. Ann N Y Acad Sci 2008, 1129:287-304.
105. Spiegel K, Tasali E, Leproult R, et al. Effects of poor and short sleep on glucose metabolism and obesity risk. Nat Rev Endocrinol 2009, 5:253-261.
106. Spiegel K, Knutson K, Leproult R, et al. Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol 2005, 99:2008-2019.
107. Chin-Chance C, Polonsky KS, Schoeller D Twenty-four hour leptin levels respond to cumulative short-term energy imbalance and predict subsequent intake. J Clin Endocrinol Metab 2000, 85:2685-2691.
108. Guilleminault C, Powell NB, Martinez S, et al. Preliminary observations on the effects of sleep time in a sleep restriction paradigm. Sleep Med 2003, 4:177-184.
109. Spiegel K, Tasali E, Penev P, et al. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 2004, 141:846-850.
110. Nedeltcheva AV, Kilkus JM, Imperial J, et al. Sleep curtailment is accompanied by increased intake of calories from snacks. Am J Clin Nutr 2009, 89:126-133.
111. Taheri S, Lin L, Austin D, et al. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 2004, 1:e62.
112. Chaput JP, Despres JP, Bouchard C, et al. Short sleep duration is associated with reduced leptin levels and increased adiposity: results from the Quebec family study. Obesity (Silver Spring) 2007, 15:253-261.
113. Littman AJ, Vitiello MV, Foster-Schubert K, et al. Sleep, ghrelin, leptin and changes in body weight during a 1-year moderate-intensity physical activity intervention. Int J Obes (Lond) 2007, 31:466-475.
114. Gottlieb DJ, Punjabi NM, Newman AB, et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 2005, 165:863-867.
115. Knutson KL, Ryden AM, Mander BA, et al. Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch Intern Med 2006, 166:1768-1774.
116. Tuomilehto H, Peltonen M, Partinen M, et al. Sleep duration is associated with an increased risk for the prevalence of type 2 diabetes in middle-aged women-the FIN-D2D Survey. Sleep Med 2008, 9:221-227.
117. Chaput JP, Despres JP, Bouchard C, et al. Association of sleep duration with type 2 diabetes and impaired glucose tolerance. Diabetologia 2007, 50:2298-2304.
118. Ayas NT, White DP, Al-Delaimy WK, et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 2003, 26:380-384.
119. Mallon L, Broman JE, Hetta J High incidence of diabetes in men with sleep complaints or short sleep duration: a 12-year follow-up study of a middle-aged population. Diabetes Care 2005, 28:2762-2767.
120. Bjorkelund C, Bondyr-Carlsson D, Lapidus L, et al. Sleep disturbances in midlife unrelated to 32-year diabetes incidence: the prospective population study of women in Gothenburg. Diabetes Care 2005, 28:2739-2744.
121. Yaggi HK, Araujo AB, McKinlay JB Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care 2006, 29:657-661.
122. Gangwisch JE, Heymsfield SB, Boden-Albala B, et al. Sleep duration as a risk factor for diabetes incidence in a large U.S. sample. Sleep 2007, 30:1667-1673.
123. Hayashino Y, Fukuhara S, Suzukamo Y, et al. Relation between sleep quality and quantity, quality of life, and risk of developing diabetes in healthy workers in Japan: the High-risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) Study. BMC Public Health 2007, 7:129.
124. Cappuccio FP, Taggart FM, Kandala NB, et al. Meta-analysis of short sleep duration and obesity in children and adults. Sleep 2008, 31:619-626.
125. Chen X, Beydoun MA, Wang Y Is sleep duration associated with childhood obesity? A systematic review and meta-analysis. Obesity (Silver Spring) 2008, 16:265-274.
126. Patel SR, Hu FB Short sleep duration and weight gain: a systematic review. Obesity (Silver Spring) 2008, 16:643-653.
127. Patel SR, Blackwell T, Redline S, et al. The association between sleep duration and obesity in older adults. Int J Obes (Lond) 2008, 32:1825-1834.
128. Van Cauter E, Knutson K Sleep and the epidemic of obesity in children and adults. Eur J Endocrinol 2008, 159:S59-S66.
129. Berkey CS, Rockett HR, Colditz GA Weight gain in older adolescent females: the internet, sleep, coffee, and alcohol. J Pediatr 2008, 153:635-639.
130. Keith SW, Redden DT, Katzmarzyk PT, et al. Putative contributors to the secular increase in obesity: exploring the roads less traveled. Int J Obes 2006, 30:1585-1594.
131. Follenius M, Brandenberger G, Bardasept J, et al. Nocturnal cortisol release in relation to sleep structure. Sleep 1992, 15:21-27.
132. Van Cauter E, van Coevorden A, Blackman JD Modulation of neuroendocrine release by sleep and circadian rhythmicity. Advances in neuroendocrine regulation of reproduction 1990, 113-122. Serono Symposia USA, Norwell, Mass. S. Yen, W. Vale (Eds.).
133. Tasali E, Leproult R, Ehrmann DA, et al. Slow-wave sleep and the risk of type 2 diabetes in humans. Proc Natl Acad Sci U S A 2008, 105:1044-1049.
134. Bergman RN Toward physiological understanding of glucose tolerance. Minimal model approach. Diabetes 1989, 38:1512-1527.
135. Kawakami N, Takatsuka N, Shimizu H Sleep disturbance and onset of type 2 diabetes. Diabetes Care 2004, 27:282-283.
136. Nilsson PM, Roost M, Engstrom G, et al. Incidence of diabetes in middle-aged men is related to sleep disturbances. Diabetes Care 2004, 27:2464-2469.
137. Meisinger C, Heier M, Loewel H Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population. Diabetologia 2005, 48:235-241.
138. Eriksson AK, Ekbom A, Granath F, et al. Psychological distress and risk of pre-diabetes and Type 2 diabetes in a prospective study of Swedish middle-aged men and women. Diabet Med 2008, 25:834-842.
139. Vgontzas AN, Bixler EO, Lin HM, et al. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab 2001, 86:3787-3794.
140. Basta M, Chrousos GP, Vela-Bueno A, et al. Chronic insomnia and stress system. Sleep Med Clin 2007, 2:279-291.
141. Motivala SJ, Tomiyama AJ, Ziegler M, et al. Nocturnal levels of ghrelin and leptin and sleep in chronic insomnia. Psychoneuroendocrinology 2009, 34:540-545.
142. Tasali E, Ip MS Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. Proc Am Thorac Soc 2008, 5:207-217.
143. Tasali E, Mokhlesi B, Van Cauter E Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest 2008, 133:496-506.
144. Romero-Corral A, Caples SM, Lopez-Jimenez F, Somers VK. Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest 2010, 137(3):711-719.
145. Phillips BG, Kato M, Narkiewicz K, et al. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 2000, 279:H234-H237.
146. Schmid SM, Hallschmid M, Jauch-Chara K, et al. A single night of sleep deprivation increases ghrelin levels and feelings of hunger in normal-weight healthy men. J Sleep Res 2008, 17:331-334.
147. Harsch IA, Konturek PC, Koebnick C, et al. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 2003, 22:251-257.
148. Takahashi K, Chin K, Akamizu T, et al. Acylated ghrelin level in patients with OSA before and after nasal CPAP treatment. Respirology 2008, 13:810-816.
149. Loube DI, Loube AA, Erman MK Continuous positive airway pressure treatment results in weight less in obese and overweight patients with obstructive sleep apnea. J Am Diet Assoc 1997, 97:896-897.
150. Redenius R, Murphy C, O'Neill E, et al. Does CPAP lead to change in BMI?. J Clin Sleep Med 2008, 4:205-209.
151. Kajaste S, Brander PE, Telakivi T, et al. A cognitive-behavioral weight reduction program in the treatment of obstructive sleep apnea syndrome with or without initial nasal CPAP: a randomized study. Sleep Med 2004, 5:125-131.
152. Chin K, Shimizu K, Nakamura T, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 1999, 100:706-712.
153. Trenell MI, Ward JA, Yee BJ, et al. Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome. Diabetes Obes Metab 2007, 9:679-687.
154. Vgontzas AN, Zoumakis E, Bixler EO, et al. Selective effects of CPAP on sleep apnoea-associated manifestations. Eur J Clin Invest 2008, 38:585-595.
155. Van Cauter E, Leproult R Sleep and diabesity in older adults. Principles and practice of geriatric sleep medicine 2009, 101-121. Cambridge University Press, Cambridge, UK. S.R. Pandi-Perumal, J.M. Monti, A.A. Monjan (Eds.).
156. Copinschi G, Van Cauter E Effects of ageing on modulation of hormonal secretions by sleep and circadian rhythmicity. Hormone Res 1995, 43:20-24.
157. Van Cauter E Hormones and sleep. The pharmacology of sleep 1995, 279-306. Springer Verlag, Berlin. A. Kales (Ed.).
158. Latta F, Leproult R, Tasali E, et al. Sex differences in nocturnal growth hormone and prolactin secretion in healthy older adults: relationships with sleep EEG variables. Sleep 2005, 28:1519-1524.
159. Van Cauter E, Leproult R, Plat L Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. JAMA 2000, 284:861-868.
160. Prinz P, Moe K, Dulberg E, et al. Higher plasma IGF-1 levels are associated with increased delta sleep in healthy older men. J Gerontol 1995, 50A:M222-M226.
161. van Coevorden A, Mockel J, Laurent E, et al. Neuroendocrine rhythms and sleep in aging men. Am J Physiol 1991, 260:E651-E661.
162. Van Cauter E, Leproult R, Kupfer DJ Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab 1996, 81:2468-2473.
163. Penev PD Association between sleep and morning testosterone levels in older men. Sleep 2007, 30:427-432.
164. Young T, Peppard PE, Taheri S Excess weight and sleep-disordered breathing. J Appl Physiol 2005, 99:1592-1599.
165. Vgontzas AN, Bixler EO, Tan TL, et al. Obesity without sleep apnea is associated with daytime sleepiness. Arch Intern Med 1998, 158:1333-1337.
166. Vgontzas AN, Tan TL, Bixler EO, et al. Sleep apnea and sleep disruption in obese patients. Arch Internal Med 1994, 154:1705-1711.
167. Resta O, Foschino Barbaro MP, Bonfitto P, et al. Low sleep quality and daytime sleepiness in obese patients without obstructive sleep apnoea syndrome. J Intern Med 2003, 253:536-543.
168. Resta O, Foschino-Barbaro MP, Legari G, et al. Sleep-related breathing disorders, loud snoring and excessive daytime sleepiness in obese subjects. Int J Obes Relat Metab Disord 2001, 25:669-675.
169. Vgontzas AN, Bixler EO, Chrousos GP Obesity-related sleepiness and fatigue: the role of the stress system and cytokines. Ann N Y Acad Sci 2006, 1083:329-344.
170. Vgontzas AN, Lin HM, Papaliaga M, et al. Short sleep duration and obesity: the role of emotional stress and sleep disturbances. Int J Obes 2008, 32:801-809.
171. Trento M, Broglio F, Riganti F, et al. Sleep abnormalities in type 2 diabetes may be associated with glycemic control. Acta Diabetol 2008, 45:225-229.
172. Einhorn D, Stewart DA, Erman MK, et al. Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus. Endocr Pract 2007, 13:355-362.
173. West SD, Nicoll DJ, Stradling JR Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax 2006, 61:945-950.
174. Resnick HE, Redline S, Shahar E, et al. Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care 2003, 26:702-709.
175. Katsumata K, Okada T, Miyao M, et al. High incidence of sleep apnea syndrome in a male diabetic population. Diabetes Res Clin Pract 1991, 13:45-51.
176. Elmasry A, Lindberg E, Berne C, et al. Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med 2001, 249:153-161.
177. Dawson A, Abel SL, Loving RT, et al. CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep. J Clin Sleep Med 2008, 4:538-542.
178. Hassaballa HA, Tulaimat A, Herdegen JJ, et al. The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea. Sleep Breath 2005, 9:176-180.
179. Babu AR, Herdegen J, Fogelfeld L, et al. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 2005, 165:447-452.
180. Harsch IA, Schahin SP, Bruckner K, et al. The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration 2004, 71:252-259.
181. Brooks B, Cistulli PA, Borkman M, et al. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effects of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 1994, 79:1681-1685.
182. West SD, Nicoll DJ, Wallace TM, et al. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 2007, 62:969-974.
183. Vgontzas AN, Legro R, Bixler EO, et al. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab 2001, 86:517-520.
184. Gopal M, Duntley S, Uhles M, et al. The role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovarian syndrome. Sleep Med 2002, 3:401-404.
185. Fogel RB, Malhotra A, Pillar G, et al. Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 2001, 86:1175-1180.
186. Tasali E, Van Cauter E, Ehrmann D Polycystic ovary syndrome and obstructive sleep apnea. Sleep Med Clin 2008, 3:37-46.
187. Tasali E, Van Cauter E, Ehrmann DA Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome. J Clin Endocrinol Metab 2006, 91:36-42.
188. Tasali E, Van Cauter E, Hoffman L, et al. Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2008, 93:3878-3884.
189. Subramanian S, Desai A, Joshipura M, et al. Practice patterns of screening for sleep apnea in physicians treating PCOS patients. Sleep Breath 2007, 11:233-237.
190. Yang HP, Kang JH, Su HY, et al. Apnea-hypopnea index in nonobese women with polycystic ovary syndrome. Int J Gynaecol Obstet 2009, 105:226-229.